The precision medicine developer Closed Loop Medicine has put forward a study showing that its approach of combining prescription drugs with dose-optimizing software could help personalize the treatment of high blood pressure.

Closed Loop described the results as a stepping stone to broader platforms, which could include other pharmaceuticals such as GLP-1s for diabetes and weight loss. The company has also been studying its programs in insomnia.

Link to full article here